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Background: Electroacupuncture (EA) stimulation has been shown to have a great therapeutic potential for treating
gastrointestinal motility disorders. However, no evidence has clarified the mechanisms contributing to the effects of EA
stimulation at the Zusanli acupoint (ST.36). This study was designed to investigate the regulative effect of EA stimulation
at the ST.36 on gastric motility and to explore its possible mechanisms.
Methods: Thirty Sprague-Dawley rats were randomly divided into three groups: the ST.36 group, the non-acupoint
group, and the control group. EA stimulation was set at 2 Hz, continuous mode, and 1 V for 30 min. The frequency and
average peak amplitude of gastric motility were measured by electrogastrography. The protein kinase C (PKC) and
mitogen-activated protein kinase (MAPK) signaling pathways were assessed using real-time polymerase chain reactions.
Caldesmon (CaD) and calponin (CaP) protein expression in the gastric antrum were detected on Western blots. A
Computed Video Processing System was used to evaluate morphological changes in smooth muscle cells (SMCs) from
the gastric antrum.
Results: EA stimulation at ST.36 had a dual effect on the frequency and average peak amplitude. Additionally, EA
stimulation at ST.36 regulated the expression of some genes in the PKC and MAPK signaling pathways, and it regulated
the expression of the CaD and CaP proteins. EA serum induced SMC contractility. Promotion of gastric motility may
correlate with up-regulation of MAPK6 (ERK3), MAPK13, and Prostaglandin-endoperoxide synthase 2 (PTGS2) gene
expression, and the down-regulation of the collagen, type I, alpha 1 (COL1A1) gene and CaD and CaP protein expression.
Inhibition of gastric motility may correlate with down-regulation of the Interleukin-1 receptor type 2 (IL1R2) and Matrix
metalloproteinase-9 (MMP9) genes, and up-regulation of CaD and CaP protein expression.
Conclusions: EA stimulation at ST.36 regulated gastric motility, and the effects were both promoting and inhibiting in
rats. The possible mechanisms may correlate with the PKC and MAPK signal transduction pathways.
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Gastric motility is one of the most critical physiological
functions of the human gut. Without coordinated motil-
ity, the digestion and absorption of dietary nutrients
cannot take place. The regulation of gastrointestinal mo-
tility is complicated and involves the contraction of
smooth muscle cells (SMCs). The contraction of SMCs
is primarily regulated by transient changes in the intra-
cellular Ca2+ concentration [1]. There are two major
pathways involved in this mechanism, namely, the
RhoA-Rho kinase pathway and the protein kinase C
(PKC) pathway [2]. Calponin (CaP), a well established
in vitro substrate for signaling proteins by PKC [3], dir-
ectly interacts with PKC [4]. Caldesmon (CaD) is an
actin and myosin binding protein that exists in two iso-
forms, which are generated by alternative splicing [5].
There is accumulating evidence for a secondary pathway
in the regulation of smooth muscle contraction that is
PKC dependent, and this pathway may be mediated by
CaP and CaD activation [6-9]. Mitogen-activated protein
kinase (MAPK) signaling pathways have also been impli-
cated in SMC contraction [10]. There are three major
groups of distinctly regulated MAPKs that lead to al-
tered gene expression. The extracellular signal related ki-
nases 1 and 2 (ERK1/2), the C-jun terminal kinase
(JNK), and the p38 MAPK are known to play important
roles in the intracellular signaling response to extracellu-
lar stimuli [11]. In addition, CaP may facilitate ERK-
dependent signaling, thus playing a significant role in
the regulation of SMC contraction [12].
Acupuncture, which has been used for thousands of
years in China, is increasingly used worldwide for the
management of various diseases [13]. It is believed that
stimulation of an acupoint can directly affect relevant
organs and achieve the effect of acupuncture therapy.
EA is a combined procedure that stimulates an acupoint
with electrical stimulation instead of with manual ma-
nipulations of needles. Numerous studies have evaluated
the effects and mechanisms of EA on gastric motility
[14-20]. Based on the evidence from these studies, EA
stimulation has been shown to have a great therapeutic
potential for treating gastrointestinal motility disorders.
The Zusanli (ST.36) is one of the most commonly used
acupoints for gastrointestinal diseases. According to the
theory of Traditional Chinese Medicine (TCM), there is
a relationship between ST.36 and the function of the
gastrointestinal tract. To date, however, no evidence has
clarified the exact mechanisms contributing to the ef-
fects of EA stimulation.
Therefore, by examining morphologic changes and
myoelectrical activity, the present study aimed to evalu-
ate the regulative effect of EA stimulation at the ST.36
acupoint on gastric motility in rats and to explore its
possible mechanisms.Methods
Animals and reagents
Thirty adult male Sprague-Dawley (SD) rats weighing
180–220 g were maintained on a 12-h light-dark cycle at
25 ± 2°C and 60% humidity with free access to food and
water. SD rats were purchased from the Experimental
Animal Center of the Fourth Military Medical Univer-
sity. All animal experiments were carried out in accord-
ance with the institutional guidelines of the Fourth
Military Medical University for the care and use of la-
boratory animals. Approval of the study protocol was
obtained from the Ethics Committee for Animal Re-
search, Fourth Military Medical University, China. Ani-
mals were randomly allocated into three groups: the
ST.36 group, the non-acupoint group, and the control
group.
Collagenase II, trypsin inhibitor, dithiothreitol alcohol
sugar, bovine serum albumin, calcium-free phosphate
buffered saline (PBS), glutaraldehyde, and Trypan blue
were purchased from Sigma Chemical Co. The Total
RNA Extraction Kit, SuperScript III Reverse Transcriptase,
and SuperArray PCR Master Mix were purchased from
Invitrogen Co. Anti-goat, anti-mouse, and anti-rabbit anti-
bodies were purchased from Shanghai Kangcheng Bio-
Engineering Co.
EA stimulation procedure
The ST.36 was located approximately 5 mm lateral to
the fibula of the hind limbs, while the non-acupoint was
located on the hind foot next to the ST.36 open 5 mm
[21]. The needles were inserted 5 mm deep into the
muscle layer of the selected acupoint and were stimu-
lated by EA at 2 Hz and 2 V using an electrical stimula-
tor (G6805-2A; Shanghai Huayi Medical Instrument
Factory, Shanghai, China). Each stimulation lasted
20 min in continuous mode, and stimulation was carried
out 1 time/day for 5 days. The rats in control group
were submitted to immobilization alone without stimu-
lation for 30 min at the same time each day.
Electrogastrography
Electrogastrography was applied using the Multichannel
Physiologic Signal Acquisition and Processing System
(mode RM-6280) after the last stimulation on the fifth
day. Following a 12-h fast (with free access to water) and
6 h without drink, the rats were anesthetized intraperito-
neally (i.p.) with 10% urethane at a dose of 1 g/kg body
and then immobilized. The first electrode was fixed to
the tail, and guided electrodes were implanted on the se-
rosal surface of the stomach 0.3 − 0.5 cm above the pyl-
orus. The electrodes were covered with 37°C normal
saline gauze, connected with wire. The experimental pa-
rameters used were as follows: frequency 400 Hz, filter
10 Hz, scanning speed 2 s/division, sensitivity 25 mV,
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time 1 h [18].
Real-time polymerase chain reaction (PCR) analysis
After the last stimulation with EA, the rats were sacri-
ficed. For control group and non-acupoint group, one
rat was randomly selected respectively. For EA group,
we first divided it into EA promoting group and EA
inhibiting group according to the results of the electro-
gastrography. And then, there rats were randomly se-
lected from both groups. Gastric antrum tissues (from
the pyloric 0.8 − 1 cm) were cut into pieces that were ap-
proximately 0.3 cm × 0.5 cm in size and immediately
placed in −70°C liquid nitrogen. Total RNA samples
were extracted using TRIZOL from different groups ac-
cording to the manufacturer’s instructions. RNA quality
was assessed spectrophotometrically on the basis of the
A260/A280 ratio. RNA samples were checked for integ-
rity of the 18S and 28S RNA by gel electrophoresis.
Total RNA (1.5 μg) was used to generate first-strand
cDNA with SuperScript III Reverse Transcriptase (1 μl)
from the isolated RNA. The real-time PCR reactions
were prepared using a SuperArray PCR Master Mix
(Cat. No. PA-112) containing the PKC and MAPK signal
pathway genes. The diluted cDNA (102 μl) was added to
each hole corresponding to the PCR chip. Then the PCR
chips were placed into the real-time PCR instrument for
the PCR reaction. The cycling conditions were as fol-
lows: 95°C for 10 min, 60°C for 15 s, and 60°C for 1 min
(40 cycles). Differences in gene expression, expressed as
fold-changes, were calculated using the 2-ΔΔCt method.
Western blots of CaD and CaP
The CaD and CaP protein levels were detected by West-
ern blotting. After treatment with EA, the rats were
sacrificed. The rats were then fixed, followed by incision
of the abdominal skin and peritoneum. The viscera were
exposed, and the central 1/3 of the gastric body was cut
into small pieces that were approximately 0.3 cm ×
0.5 cm in size. The pieces were immediately stored at
-70°C in liquid nitrogen. Briefly, cell extracts (30 μg)
from the upper 1/3 of the middle of the gastric body were
separated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and then transferred to
nitrocellulose membranes. The filters were blocked with
Tris-buffered saline (TBS)/5% milk, followed by incuba-
tion with polyclonal antibodies against CaD (1:3000 di-
lution), CaP (1:3000 dilution), and β-actin (1:10000).
After the membranes were washed, they were incubated
with secondary peroxidase-conjugated antibodies diluted
1:5000 in TBS with 0.01% Tween 20. The antibody de-
tection system was used, and the membranes were ex-
posed to X-ray film according to the manufacturer’s
instructions.Serum preparation
Serum was prepared as previously described with modi-
fication [22]. After the last stimulation with EA, all rats
were sacrificed. Next, 6 ml of blood was taken from the
carotid of each rat. The blood was kept still for 1 h, and
then centrifuged at 3000 rpm for 15 min. The serum
was collected, filtered to remove bacteria, and 1.5 ml
was packed in an EP tube, which was stored at −70°C in
liquid nitrogen.
Effects of EA serum on SMC contractility
Five normal SD rats were anesthetized i.p. with 10% ur-
ethane at a dose of 1 g/kg body weight. After being anes-
thetized, the abdominal skin and peritoneum were
incised, and the viscera were exposed. The whole stom-
ach was cut out, and the gastric antrum tissues were iso-
lated and immediately placed in oxygen saturated PBS
with penicillin (100 U/ml) and streptomycin (100 μg/ml)
at 4°C. After being rinsed, the tissues were transferred to
oxygen saturated HEPES, spread and fixed on a silica gel
plate with a fine-needle. The mucosal layer was carefully
cut off, exposing the circular mucosa, which was clipped
into 9 − 10 muscle strips (1 mm × 4 mm), placed in
Tyrode’s solution, and kept at 4°C in the refrigerator for
approximately 15 min. The muscle strips were digested
in 1% collagenase type II, 0.05% trypsin inhibitor, 0.05%
dithiothreitol alcohol sugar, and 0.2% bovine serum albu-
min enzyme in a water bath for 25 min at 36°C. After di-
gestion, the mixture was rinsed with enzyme-free
HEPES, incubated for 30 min, and filtered with a 200
screen mesh to collect the free single gastric SMCs. Cell
viability was measured with the Trypan blue test. The liv-
ing cells were more than 95% at a density of 106 cells/ml.
The isolated SMCs were randomly divided into the
normal serum group, ST.36 serum group, and non-
acupoint serum group. SMCs suspensions (50 μl) at a
density of 1.0 × 106 cells/ml were placed in 96-well
plates. Each serum sample was inactivated after 30 min
in a 56°C water bath, and then diluted 1:2 with HEPES.
Serum (50 μl) from the different groups was added to
SMCs, mixed with a pipette for 30 s, and fixed with
30 μl 2.5% glutaraldehyde. Cell length was assessed with
a Computed Video Processing System (DP2-BSW),
which was used to calculate the shrinkage percentage.
The cell shrinkage percentage = (cell length before treat-
ment − cell length after treatment)/cell length before
treatment × 100%.
Statistical analysis
Data were expressed as mean ± S.D. One-way analysis of
variance followed by Bonferroni’s multiple comparison
test was applied with SPSS 10.0 software. The ΔCt
values obtained from the real-time PCR, which were
used to calculate the fold-change differences (expressed
Table 1 Gene change comparing EA promoting group with control group
Signal pathway Gene Sites EA/control
(Fold change)
EA/control
(Fold up- or down-regulation)
MAPK MAPK6 (ERK3) D02 2.39 2.39
MAPK MAPK13 D10 2.86 2.86
PKC IL1R1 F08 2.18 2.18
PKC PRKCA G01 2.40 2.40
PKC PTGS2 G02 2.72 2.72
PKC IL1R2 F09 0.26 −3.85
Fold-change (2-ΔΔCt) is the normalized gene expression (2-ΔCt) in the test sample divided by the normalized gene expression (2-ΔCt) in the control sample. Fold-
regulation represents the fold-change results in a biologically meaningful way. Fold-change values greater than one indicate a positive- or up-regulation, and the
fold-regulation is equal to the fold-change. Fold-change values less than one indicate a negative or down-regulation, and the fold-regulation is the negative
inverse of the fold-change.
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tical analysis. A p-value < 0.05 or a fold-change > 2 was
defined as statistically significant for all analyses.
Results
Effects of EA on gastric motility
EA at ST.36 produced significant changes in the abso-
lute value of the average peak amplitude and frequency
compared with the control or non-acupoint groups (P <
0.01). In contrast, EA at the non-acupoint did not in-
duce significant changes in gastric motility compared
with the control group (Additional file 1: Figure S1).
Two types of gastric motor patterns were observed for
the ST.36 group in the 10 rats tested according the aver-
age peak: rats with positive average peak were judged to
promoting pattern, while rats with negative average peak
were judged to promoting pattern. The results showed 5
(50.0%) rats showed the ST.36 promoting pattern and 5
(50.0%) rats showed the ST.36 inhibiting pattern. In rats
with the ST.36 promoting pattern, the average peak
amplitude and frequency values were 47.13 ± 0.44 and
0.19 ± 0.06, respectively. In rats with the ST.36 inhibiting
pattern, the average peak amplitude and frequency
values were −43.41 ± 0.62 and 0.17 ± 0.03, respectively
(Additional file 2: Table S1).
Effects of EA on the PKC and MAPK signaling pathways
EA at ST.36 significantly regulated the expression of
some genes in the PKC and MAPK signaling pathways.
Table 1 lists the results from the microarray analysis ofTable 2 Gene change comparing EA inhibitory group with co
Signal pathway Gene Sites
PKC IL1R2 F09
PKC MMP9 F11
Fold-change (2-ΔΔCt) is the normalized gene expression (2-ΔCt) in the test sample div
regulation represents the fold-change results in a biologically meaningful way. Fold
fold-regulation is equal to the fold-change. Fold-change values less than one indica
inverse of the fold-change.the ST.36 promoting group (as compared to the control
group). The expression of many genes was increased
after EA stimulation, including ERK3, MAPK13, IL1R1,
PRKCA, and PTGS2. Other genes showed decreased ex-
pression after EA stimulation, including IL1R2. Table 2
lists the results from the microarray analysis of the
ST.36 inhibiting group (as compared to the control
group). The gene expression of IL1R2 and MMP9 were
decreased after EA stimulation.
Table 3 lists the results from the microarray analysis of
the ST.36 promoting group (as compared to the non-
acupoint group). The expression of the COL1A1 gene
was increased after EA stimulation. The expression of
the IL1R2 and SERPINE1 genes were decreased after EA
stimulation. Table 4 lists results from the microarray
analysis of the ST.36 inhibiting group (as compared to
the non-acupoint group). Many of the genes showed de-
creased expression after EA stimulation, including the
ERK3, JNK3, p38bMAPK, MAPK13, p38MAPK, ERK1,
FGF2, IL1R1, IL1R2, MYC, PRKCA, and PTGS2 genes.
The expression of the COL1A1 gene was increased after
EA stimulation.
Effects of EA on CaD and CaP protein expression
Stimulation with EA significantly increased CaD and
CaP protein expression in the ST.36 inhibiting group
compared with the non-acupoint group, whereas stimu-
lation with EA significantly decreased CaD and CaP pro-
tein expression in ST.36 promoting group compared




(Fold up- or down-regulation)
0.24 −4.26
0.21 −4.68
ided by the normalized gene expression (2-ΔCt) in the control sample. Fold-
-change values greater than one indicate a positive- or up-regulation, and the
te a negative or down-regulation, and the fold-regulation is the negative
Table 3 Gene change comparing EA promoting group with non-acupoint group
Signal pathway Gene Sites EA/Non-acupoint
(Fold change)
EA/Non-acupoint
(Fold up- or down-regulation)
PKC COL1A1 F05 3.60 3.60
PKC IL1R2 F09 0.39 −2.54
PKC SERPINE1 G04 0.48 −2.07
Fold-change (2-ΔΔCt) is the normalized gene expression (2-ΔCt) in the test sample divided by the normalized gene expression (2-ΔCt) in the control sample. Fold-
regulation represents the fold-change results in a biologically meaningful way. Fold-change values greater than one indicate a positive- or up-regulation, and the
fold-regulation is equal to the fold-change. Fold-change values less than one indicate a negative or down-regulation, and the fold-regulation is the negative
inverse of the fold-change.
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As shown in Additional file 3: Figure S2 and Additional
file 4: Table S2, cell morphology was observed under the
light microscope after treatment with different types of
serum. There were no differences in cell length before
the addition of serum (p > 0.05). ST.36 serum increased
SMC contractility (60.22 ± 3.84 μm) compared with the
control serum (96.02 ± 6.24 μm) or the non-acupoint
serum (97.33 ± 6.97 μm). The contraction percentage
was 41% after stimulation with ST.36 serum, whereas
the contraction percentages were 7% and 10% after
stimulation with either the non-acupoint serum or con-
trol serum, respectively.
Discussion
The present study demonstrated that EA stimulation at
ST.36 had a regulative effect on gastric motility in rats
that was either stimulatory or inhibitory. The stimulating
effect of EA may act through the PKC and MAPK sig-
naling pathways.Table 4 Gene change comparing EA inhibitory group with no
Signal pathway Gene Sites
MAPK MAPK6 (ERK3) D02
MAPK MAPK10 (JNK3) D07
MAPK MAPK11 (p38bMAPK) D08
MAPK MAPK13 D10
MAPK MAPK3 (ERK1) G11









Fold-change (2-ΔΔCt) is the normalized gene expression (2-ΔCt) in the test sample div
regulation represents the fold-change results in a biologically meaningful way. Fold
fold-regulation is equal to the fold-change. Fold-change values less than one indica
inverse of the fold-change.The effects of EA on gastric motility have been exten-
sively studied in both animals and humans due to the
availability of electrogastrography. It is well known that
gastric myoelectrical activity consists of slow waves and
spikes. Spikes are directly associated with the appearance
of contractions. Slow waves do not evoke gastrointestinal
contractility, but they determine the maximum fre-
quency of gastric contractions.
The most often used acupoint in treating gastrointes-
tinal disorders is the ST.36. It is commonly believed that
acupuncture may exert promoting and inhibiting effects
on gastrointestinal motility depending on the stimulated
acupoint. In humans, it has been shown that EA stimu-
lation at ST.36 had dual effects on gastric peristalsis that
are either facilitative or inhibitory [15,23]. Although pa-
tients suffering from gastrointestinal diseases have bene-
fited from the application of acupuncture at ST.36, but
the exact molecular mechanisms are still unclear. In
dogs, EA at ST.36 increased the regularity of gastric slow



















ided by the normalized gene expression (2-ΔCt) in the control sample. Fold-
-change values greater than one indicate a positive- or up-regulation, and the
te a negative or down-regulation, and the fold-regulation is the negative
Figure 1 Effects of EA stimulation on Caldesmon (CaD) and Calponin (CaP) protein levels. A. Expression of Caldesmon protein levels by
Western blotting. B. Densitometric analysis Caldesmon protein levels normalized by β-actin; C. Expression of Calponin protein levels by Western
blotting; D Densitometric analysis Calponin protein levels normalized by β-actin. CaD: Caldesmon; CaP: calponin; 1: non-acupoint group; 2–4: EA
inhibiting group; 5–7: EA promoting group. *P < 0.05 compard to non-acupoint group.
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hibitory, on gastric motility [26,27]. Further study re-
vealed that the stimulatory effect is mediated via
cholinergic pathways, while the inhibitory effect isindependent of the sympathetic pathway [28]. The gen-
eral theory of acupuncture medicine is premised on the
concept of Yin and Yang, and acupuncture is believed to
modify the imbalance between Yin and Yang. The effects
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ated via the interaction between the neurotransmission
of GABA and glutamate in the brain stem.
In the current paper, EA stimulation at ST.36 was ef-
fective in regulating gastric motility, as demonstrated by
the significant increase in peak amplitude and frequency.
In addition, the lack of such a response when the same
stimulation was performed at the non-acupoint was in-
dicative of the specificity of this effect. According to the
peak amplitude and frequency, the ST.36 group was fur-
ther divided into promoting and inhibitory patterns,
since EA showed a dual effect. To further explore the
mechanisms by which EA regulates gastric motility, we
isolated SMCs from the stomach and observed the effect
of ST.36 serum on SMC contractility using serologic
pharmacological testing methods. The results showed
that ST.36 serum significantly increased SMC contractil-
ity; whereas the effects produced by normal or non-
acupoint serum were not obvious.
Recent investigations suggested that the effects of EA
stimulation are mediated through the opioid system [29]
or through its stimulating effect on vagal activity [30];
however, the precise mechanisms by which EA affects
gastric motility were not fully understood. Previous find-
ings also indicated that PKC levels were increased after
stimulation with EA [31]. Therefore, we selected the
PKC and MAPK pathways as targets for mediating the
stimulatory effects of EA on gastric mobility. Moreover,
CaP and CaD may play a role in the regulation of gastro-
intestinal motility during physiological and pathological
adaptation. Up-regulation of CaP and CaD expression
inhibited gastrointestinal motility, and down-regulation
of CaP and CaD expression promoted gastrointestinal
motility [32,33]. ERK1/2, a member of the MAPK family,
has been shown to play a significant role in the regula-
tion of smooth muscle contraction [34]. According to
our microarray results, promotion of gastric motility
may correlate with up-regulation of MAPK6 (ERK3),
MAPK13, and PTGS2 gene expression, and down-
regulation of COL1A1 gene expression. Inhibition of
gastric motility may correlate with down-regulation of
IL1R2 and MMP9 gene expression. Western blots
showed up-regulation of CaD and CaP protein expres-
sion inhibited gastric motility, whereas down-regulation
of CaD and CaP protein expression promoted gastric
motility. These results demonstrate that CaD and CaP
may play a role in the regulation of gastrointestinal mo-
tility during physiological and pathological adaptation.
There were some limitations in the present study that
should be mentioned. First, we did not investigate
whether the inhibitors of PKC and MAPK could affect
or block the regulatory effect of EA stimulation at ST.36
on gastric mobility. Further studies will be required to
investigate the influences of PKC and MAPK inhibitors.Second, future investigations will focus on fully under-
standing the roles of each change in gene expression
upon the regulation of gastric mobility.Conclusions
In summary, our findings demonstrate that EA stimula-
tion at ST.36 regulated gastric motility. EA stimulation
at ST.36 exerted dual effects on gastric motility that
were either stimulatory or inhibitory. In addition, regula-
tion of gastric motility may correlate with the PKC and
MAPK signal transduction pathways.Additional files
Additional file 1: Figure S1. Effects of EA stimulation on gastric motility.
Gastric motility was measured by electrogastrography. A. Control, B. ST.36,
C. Non-acupoint. Stimulation with EA at ST.36 increased the average peak
amplitude and frequency. Gastric waves showed dual changes in the ST.36
group compared with the control or non-acupoint group. Values are
expressed as the mean ± S.D. (n = 10). *p < 0.05, **p < 0.01 vs. control group.
#p < 0.05, ##p < 0.01 vs. non-acupoint group.
Additional file 2: Table S1. Effects of EA on gastric myoelectrical
activity. The ST.36 group was further divided into EA promoting and EA
inhibiting groups according to the gastric waves. Values are expressed as
mean ± S.D (n = 5).
Additional file 3: Figure S2. Effects of EA stimulation on gastric SMC
contractility. Cell morphology was observed using a light microscope
(×200 magnification). The length of the cell and the contraction
percentage was measured with a Computer Image Analysis System.
O. SMCs; A. SMCs + control serum; B. SMCs + ST.36 serum; C. SMCs +
non-acupoint serum.
Additional file 4: Table S2. Effects of serum on SMC contractility. As
assessed by the Computed Video Processing System, Zusanli serum
resulted in significant contractility in SMCs. Results are expressed as the
mean ± S.D (n = 10). *p < 0.05 **p < 0.01 vs. control serum group.
#p < 0.05, ##p < 0.01 vs. non-acupoint serum.Competing interests
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